Health Economics & Outcomes Research
The current situation
Health economics and outcomes research, is a critical part of an effective go-to-market strategy.
In this increasingly competitive marketplace in which governments, insurers, and other third-party payers are all working to control costs, companies must provide information about the effectiveness of their products, from both health outcomes and financial perspectives, for them to gain adoption.
Clinical trials can answer limited questions about specific interventions, but the cost, time, and resources required grow exponentially as the questions become more complex.
The Archimedes advantage
The Archimedes Model provides companies with a simulated environment for answering complex questions, including comperative effectiveness questions, far more rapidly and inexpensively than would otherwise be possible.
The Model is a clinically realistic simulation model of human physiology, diseases, behaviors, interventions, and healthcare systems. It gives users the power to quantify the value of a device or drug in different populations and share that information with others.
How you can use the Archimedes Model
Cardio-Metabolic Risk (CMR) Forecast Dataset. The CMR forecast dataset provides data from 19 simulated trials that addressed 20 interventions in U.S. patients. The dataset is the most economical solution to answer questions about efficacy, cost, and target markets for interventions related to cardio-metabolic risk. More...
ARCHeS Innovator. ARCHeS Innovator is a comprehensive web-based tool that gives you direct access to much of the power of the Archimedes Model. It enables you to set up multi-scenario studies and run your own analyses to examine and compare conditions, treatments, and outcomes related to coronary artery disease, stroke, diabetes and its complications, obesity, hypertension, dyslipidemia, and smoking. It can also be used to create new or hypothetical treatments, either by drawing on the results of phase 2 clinical trials or by specifying effects on biomarkers and/or health outcomes. More...
Modeling & Consulting Services. We provide comprehensive support to help you run custom simulations and build custom disease models. Our team of scientists and physicians will work with you to develop simulations to quantify the potential value of your device or drug in terms of outcomes and costs. More...
